In this study, we investigated CTCs during vulvar cancer as well as cervical cancer stage-dependent therapy and showed that frequencies and absolute numbers of cytokeratin+ CD45− CTCs individually differed in patients during therapy and linked therapy-induced increased CTC numbers with relapse on follow-up. This evidence concerns the gene PTPRC and cervical carcinoma.